$BNGO
Bionano Genomics, Inc. Stock $bngo

$bngo Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000141169023000082 Filed on November 08, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$10.72M	$9.318M
YoY Change	30.51%	29.04%
Cost Of Revenue	$8.283M	$6.569M
YoY Change	29.22%	21.38%
Gross Profit	$2.438M	$2.749M
YoY Change	35.07%	51.96%
Gross Profit Margin	22.74%	29.5%
Selling, General & Admin	$15.69M	$24.90M
YoY Change	-33.29%	17.35%
% of Gross Profit	643.56%	905.64%
Research & Development	$11.70M	$13.79M
YoY Change	-16.49%	8.19%
% of Gross Profit	479.94%	501.46%
Depreciation & Amortization	$3.647M	$3.680M
YoY Change	29.46%	51.38%
% of Gross Profit	149.59%	133.87%
Operating Expenses	$27.39M	$38.68M
YoY Change	-27.02%	13.91%
Operating Profit	-$24.95M	-$113.2M
YoY Change	-30.16%	252.15%
Interest Expense	-$3.709M	$71.00K
YoY Change	-633.67%	-2.74%
% of Operating Profit
Other Income/Expense, Net	-$15.27M	$685.0K
YoY Change	38062.5%	86.14%
Pretax Income	-$43.93M	-$112.5M
YoY Change	19.13%	254.07%
Income Tax	-$36.00K	$39.00K
% Of Pretax Income
Net Earnings	-$43.89M	-$112.6M
YoY Change	13.48%	253.88%
Net Earnings / Revenue	-409.39%	-1208.05%
Basic Earnings Per Share		-$3.22
Diluted Earnings Per Share	-$1.10	-$3.22
COMMON SHARES
Basic Shares Outstanding	38.84M shares	35.35M shares
Diluted Shares Outstanding		35.00M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$66.70M	$63.60M
YoY Change	-41.08%	-64.71%
Cash & Equivalents	$17.90M	$34.60M
Short-Term Investments	$48.80M	$29.00M
Other Short-Term Assets	$976.0K	$5.900M
YoY Change	-59.54%	-17.27%
Inventory	$27.60M	$33.51M
Prepaid Expenses
Receivables	$9.319M	$8.669M
Other Receivables	$342.0K	$0.00
Total Short-Term Assets	$140.1M	$104.5M
YoY Change	-10.92%	-52.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$23.35M	$21.27M
YoY Change	29.49%	34.09%
Goodwill	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Intangibles	$33.97M	$35.77M
YoY Change	-17.42%	58.36%
Long-Term Investments
YoY Change
Other Assets	$7.431M	$10.21M
YoY Change	207.83%	1173.07%
Total Long-Term Assets	$74.29M	$77.37M
YoY Change	-50.54%	-26.67%
TOTAL ASSETS
Total Short-Term Assets	$140.1M	$104.5M
Total Long-Term Assets	$74.29M	$77.37M
Total Assets	$214.4M	$181.9M
YoY Change	-30.28%	-43.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$10.38M	$15.37M
YoY Change	-17.15%	63.38%
Accrued Expenses	$8.089M	$11.55M
YoY Change	-23.34%	-1.62%
Deferred Revenue	$783.0K	$811.0K
YoY Change	-10.1%	-16.91%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$272.0K	$300.0K
YoY Change	-4.56%	4.17%
Total Short-Term Liabilities	$100.0M	$40.19M
YoY Change	178.75%	19.98%
LONG-TERM LIABILITIES
Long-Term Debt	$3.585M	$3.600M
YoY Change	-0.94%	-0.72%
Other Long-Term Liabilities	$14.63M	$19.10M
YoY Change	-21.33%	295.45%
Total Long-Term Liabilities	$18.22M	$22.70M
YoY Change	-18.01%	168.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$100.0M	$40.19M
Total Long-Term Liabilities	$18.22M	$22.70M
Total Liabilities	$118.2M	$62.91M
YoY Change	103.51%	49.93%
SHAREHOLDERS EQUITY
Retained Earnings	-$581.2M	-$537.3M
YoY Change	66.68%	73.3%
Common Stock	$677.3M	$656.4M
YoY Change	13.03%	10.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$96.16M	$119.0M
YoY Change
Total Liabilities & Shareholders Equity	$214.4M	$181.9M
YoY Change	-30.28%	-43.8%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$43.89M	-$112.6M
YoY Change	13.48%	253.88%
Depreciation, Depletion And Amortization	$3.647M	$3.680M
YoY Change	29.46%	51.38%
Cash From Operating Activities	-$29.78M	-$26.29M
YoY Change	-13.73%	-10.8%
INVESTING ACTIVITIES
Capital Expenditures	$745.0K	$80.00K
YoY Change	11.69%	-127.59%
Acquisitions
YoY Change
Other Investing Activities	-$54.63M	$33.50M
YoY Change	-544.96%	306.41%
Cash From Investing Activities	-$55.37M	$33.43M
YoY Change	-576.94%	320.34%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	68.48M	12.59M
YoY Change	46806.85%	-44.42%
NET CHANGE
Cash From Operating Activities	-29.78M	-26.29M
Cash From Investing Activities	-55.37M	33.43M
Cash From Financing Activities	68.48M	12.59M
Net Change In Cash	-16.67M	19.73M
YoY Change	-26.77%	1644.47%
FREE CASH FLOW
Cash From Operating Activities	-$29.78M	-$26.29M
Capital Expenditures	$745.0K	$80.00K
Free Cash Flow	-$30.52M	-$26.37M
YoY Change	-13.24%	-9.64%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001411690
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	38840337	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	5091000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29014000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	108095000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8669000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7022000	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5857000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7329000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	0	usd
CY2022Q4	us-gaap	Goodwill Goodwill	77289000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2414000	usd
CY2022Q4	us-gaap	Assets Assets	307502000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	12534000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10552000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	871000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2260000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	285000	usd
CY2023Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	10000000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	9382000	usd
CY2023Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	35349000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29718000	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28970000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	4000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	5.49
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	reportingunit
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P3M
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2023Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	0.1
CY2023Q2	bngo	Stockholders Equity Reverse Stock Split Percentage Of Outstanding Common Stock Are Present StockholdersEquityReverseStockSplitPercentageOfOutstandingCommonStockArePresent	0.33
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34568000	usd
CY2023Q3	bngo	Inventory Current InventoryCurrent	26429000	usd
CY2022Q4	bngo	Inventory Current InventoryCurrent	29761000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	77280000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q3	us-gaap	Costs And Expenses CostsAndExpenses	115961000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-113212000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	71000	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	73000	usd
	us-gaap	Interest Expense InterestExpense	221000	usd
	us-gaap	Interest Expense InterestExpense	223000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-183000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	331000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-93840000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	79000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	14848000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-37124000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	459000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	231486000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3932000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-93919000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.85
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.28
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.28
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	32246000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28663000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	28663000	shares
	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	-1143000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-140000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	17000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	96000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1031000	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-31713000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-187571000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	337118000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	15000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5102000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	136000	usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5777000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	75000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-32158000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-281000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	284734000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	111000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6059000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	22550000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-31809000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	96000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	281741000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	249398000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	23000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3882000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	17802000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	92000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-38912000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	355000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	214756000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3992000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	12661000	usd
CY2023Q3	us-gaap	Restricted Stock Value Shares Issued Net Of Tax Withholdings RestrictedStockValueSharesIssuedNetOfTaxWithholdings	-61000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-112566000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	217000	usd
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	92000	usd
	bngo	Employee Stock Purchase Plan Compensation Expense EmployeeStockPurchasePlanCompensationExpense	75000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	23000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	262000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	45331000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	118999000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-93919000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10112000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	6855000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	77280000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	153000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	168000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	309000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-695000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	38000	usd
	bngo	Non Cash Lease Expense NonCashLeaseExpense	383000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	-23000	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	11806000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	16938000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	2528000	usd
	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	237000	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	88000	usd
	bngo	Cost Of Leased Equipment Sold To Customer CostOfLeasedEquipmentSoldToCustomer	204000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1646000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1134000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3819000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	18121000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1376000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3387000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	7798000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	52000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2401000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1233000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	967000	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	2067000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95402000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90299000	usd
	bngo	Proceeds From Business Combination Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationReturnOfPurchaseConsiderationFromEscrow	0	usd
	bngo	Proceeds From Business Combination Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationReturnOfPurchaseConsiderationFromEscrow	694000	usd
	bngo	Proceeds From Business Combination Two Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationTwoReturnOfPurchaseConsiderationFromEscrow	96000	usd
	bngo	Proceeds From Business Combination Two Return Of Purchase Consideration From Escrow ProceedsFromBusinessCombinationTwoReturnOfPurchaseConsiderationFromEscrow	0	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	946000	usd
	bngo	Payments For Property And Equipment PaymentsForPropertyAndEquipment	1055000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	4485000	usd
	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	63208000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	84866000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	135386000	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	0	usd
	us-gaap	Payments For Construction In Process PaymentsForConstructionInProcess	686000	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	26000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	79531000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	71157000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	34000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	26000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	46411000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	23128000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1161000	usd
	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	578000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	22861000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-124000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	29477000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3595000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5491000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	24571000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	34968000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Disposal Group Including Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsDisposalGroupIncludingDiscontinuedOperations	28166000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34568000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	28166000	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	400000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	0	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34968000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	28166000	usd
	us-gaap	Interest Paid Net InterestPaidNet	221000	usd
	us-gaap	Interest Paid Net InterestPaidNet	222000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1938000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1166000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	7112000	usd
	bngo	Transfer Of Instruments And Servers To Property And Equipment From Inventory TransferOfInstrumentsAndServersToPropertyAndEquipmentFromInventory	5500000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	434000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	857000	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	0	usd
	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	106000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	517000	usd
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain amounts reported in prior years have been reclassified to conform with the presentation in the current year. These reclassifications had no effect on the reported results of operations.</span></div>
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	34600000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	29000000	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-537300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-95400000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	77300000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	7100000	usd
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3862000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	3282000	shares
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9318000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7221000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25395000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19587000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9318000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	7221000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	25395000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	19587000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1000000	usd
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.377
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.507
CY2023Q3	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.116
CY2023Q3	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	200000	usd
CY2022Q3	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	100000	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	1300000	usd
	bngo	Contract With Customer Liability Revenue Recognized Excluding Deferred Amounts ContractWithCustomerLiabilityRevenueRecognizedExcludingDeferredAmounts	600000	usd
CY2023Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	9023000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	7315000	usd
CY2021Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	5624000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	690000	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	8669000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7022000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	4934000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	293000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-98000	usd
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	37000	usd
CY2023Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	354000	usd
CY2023Q3	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	7590000	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies Net Of Reserves InventoryRawMaterialsAndSuppliesNetOfReserves	5319000	usd
CY2023Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	10541000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	7055000	usd
CY2023Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	15383000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	17387000	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	33514000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	29761000	usd
CY2023Q3	bngo	Inventory Current InventoryCurrent	26429000	usd
CY2022Q4	bngo	Inventory Current InventoryCurrent	29761000	usd
CY2023Q3	us-gaap	Inventory Noncurrent InventoryNoncurrent	7085000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48380000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	12716000	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	35664000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	48380000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7339000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	41041000	usd
CY2023Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8509000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7002000	usd
CY2023Q3	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2022Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	17000	usd
CY2023Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	724000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	825000	usd
CY2023Q3	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	834000	usd
CY2022Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	613000	usd
CY2023Q3	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	308000	usd
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	12.23
CY2022Q4	bngo	Professional Fees And Royalties Current ProfessionalFeesAndRoyaltiesCurrent	210000	usd
CY2023Q3	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	572000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	489000	usd
CY2023Q3	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	71000	usd
CY2022Q4	bngo	Accrued Clinical Study Fees Current AccruedClinicalStudyFeesCurrent	250000	usd
CY2023Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	517000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1146000	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11552000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10552000	usd
CY2023Q3	bngo	Stockholders Equity Note Stock Split Multiplier Per Share StockholdersEquityNoteStockSplitMultiplierPerShare	5.90
CY2022Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	700000	shares
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	34.59
CY2022Q3	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	23100000	usd
CY2022Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	600000	usd
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	5600000	shares
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	8.28
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	46500000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1200000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	436000	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	59.60
CY2022	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P0Y9M3D
CY2022Q4	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	273000	usd
	bngo	Class Of Warrant Or Right Number Of Securities Granted In Period ClassOfWarrantOrRightNumberOfSecuritiesGrantedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Number Of Securities Exercised In Period ClassOfWarrantOrRightNumberOfSecuritiesExercisedInPeriod	0	shares
	bngo	Class Of Warrant Or Right Number Of Securities Canceled In Period ClassOfWarrantOrRightNumberOfSecuritiesCanceledInPeriod	396000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	40000	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	653.98
	bngo	Class Of Warrant Or Right Weighted Average Remaining Contractual Term Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageRemainingContractualTermOfWarrantsOrRights	P1Y3M
CY2023Q3	bngo	Class Of Warrant Or Right Aggregate Intrinsic Value Of Warrants Or Rights ClassOfWarrantOrRightAggregateIntrinsicValueOfWarrantsOrRights	0	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2402000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	32.80
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2068000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1427000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	25000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	298000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	28.85
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3527000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.86
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y6M7D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	6000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	1308000	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	31.94
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P7Y9M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	0	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	2.32
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	8.24
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3992000	usd
CY2022Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6059000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11806000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16938000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.043
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.031
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.040
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.022
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.789
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.710
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.752
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.703
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	648000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	81000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2684000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	330000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2788000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	338000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	729000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	347000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	255000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	356000	usd
CY2023Q3	bngo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q3	bngo	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	5594000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7104000	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	7046000	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	833000	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	3175000	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	6271000	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	3871000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	6	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions	16	security
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	6	security
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Number Of Positions DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerNumberOfPositions	24	security
CY2023Q3	us-gaap	Interest Receivable InterestReceivable	300000	usd
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	500000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	29087000	usd
CY2023Q3	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	0	usd
CY2023Q3	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	73000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	29014000	usd
CY2023Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	29087000	usd
CY2023Q3	bngo	Debt Securities Available For Sale Unrealized Gains DebtSecuritiesAvailableForSaleUnrealizedGains	0	usd
CY2023Q3	bngo	Debt Securities Available For Sale Unrealized Loss DebtSecuritiesAvailableForSaleUnrealizedLoss	73000	usd
CY2023Q3	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	29014000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	94914000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Gain Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedGainMaturityAllocatedAndSingleMaturityDateYearOne	1000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Loss Maturity Allocated And Single Maturity Date Year One DebtSecuritiesAvailableForSaleUnrealizedLossMaturityAllocatedAndSingleMaturityDateYearOne	1000000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	93915000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	109182000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Gains DebtSecuritiesAvailableForSaleUnrealizedGains	1000	usd
CY2022Q4	bngo	Debt Securities Available For Sale Unrealized Loss DebtSecuritiesAvailableForSaleUnrealizedLoss	1088000	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	108095000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	8803000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	19000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	20211000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	54000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	29014000	usd
CY2023Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	73000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	31662000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	116000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	74452000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	972000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	106114000	usd
CY2022Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1088000	usd

Files In Submission

Name	View Source	Status
0001411690-23-000082-index-headers.html	Edgar Link	pending
0001411690-23-000082-index.html	Edgar Link	pending
0001411690-23-000082.txt	Edgar Link	pending
0001411690-23-000082-xbrl.zip	Edgar Link	pending
bngo-20230930.htm	Edgar Link	pending
bngo-20230930.xsd	Edgar Link	pending
bngo-20230930xexx102.htm	Edgar Link	pending
bngo-20230930xexx311.htm	Edgar Link	pending
bngo-20230930xexx312.htm	Edgar Link	pending
bngo-20230930xexx321.htm	Edgar Link	pending
bngo-2023x09x30xexx31.htm	Edgar Link	pending
ex101-employmentagreemente.htm	Edgar Link	pending
ex21-bionanoxsecondamendme.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_0.jpg	Edgar Link	pending
image_3a.jpg	Edgar Link	pending
image_4a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
bngo-20230930_cal.xml	Edgar Link	unprocessable
bngo-20230930_def.xml	Edgar Link	unprocessable
bngo-20230930_lab.xml	Edgar Link	unprocessable
bngo-20230930_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bngo-20230930_htm.xml	Edgar Link	completed
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNGO
Bionano Genomics, Inc. Stock $bngo

2023 Q4 Form 10-Q Financial Statement

#000141169023000082 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO Bionano Genomics, Inc. Stock $bngo

2023 Q4 Form 10-Q Financial Statement

#000141169023000082 Filed on November 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNGO
Bionano Genomics, Inc. Stock $bngo